Ham. There’s an ICER report on cost effectiveness ( which cohort etc ) for Vascepa Are U familiar with it ? Vascepa is very cost effective for prior event ( ie you have stents or had a bypass ) CAD patients . Show me the data that it’s cost effective for a patient simply with high TG’s that is not diagnosed CAD Kiwi